Salience Clinical Consulting

From a regulatory standpoint, this isn’t just interesting it’s a problem. Agencies evaluate drug products. They don’t regulate psychotherapy. If a meaningful, inseparable portion of the treatment effect comes from the therapeutic container rather than the molecule, then defining the independent variable becomes genuinely complicated and your development program needs to address that directly.